Riskpilot← Back to searchSign inGet full accessFAGERSTRAND APOTEK AS
ASActiveOrg 924954582Myklerudveien 122, 1454 FagerstrandRetail sale of pharmaceutical products · NACE 4773Est. 20200 employees
Revenue 2022
NOK 13,3M
+5% vs 2021
EBITDA margin
1.3%
-71% vs 2021
Equity ratio
16.8%
Financial strength
Net profit 2022
NOK -16K
-104% vs 2021
| Revenue | NOK 13,3M | +5% |
| EBITDA | NOK 177K | -71% |
| Net profit | NOK -16K | -104% |
| Total assets | NOK 3,4M | -7% |
| Equity | NOK 574K | -3% |
| Employees | 0 | — |
Legal name
FAGERSTRAND APOTEK AS
Org number
924954582
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
21. april 2020
Share capital
NOK 500 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Eie og drive apotek og alt hva hermed står i forbindelse
Address
Myklerudveien 122, 1454 Fagerstrand
Phone
+4763002390
Email
fagerstrand@dittapotek.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 |
|---|---|---|---|
| Revenue | 3 556 | 12 637 | 13 306 |
| Staff expenses | −816 | −2 048 | −2 623 |
| EBITDA | −197 | 614 | 177 |
| Depreciation & amort. | −58 | −175 | −175 |
| EBIT | −255 | 440 | 3 |
| Net financials | −27 | −49 | −22 |
| Profit before tax | −282 | 390 | −20 |
| Tax | −0 | 23 | −4 |
| Net profit | −282 | 367 | −16 |
| Item | 2020 | 2021 | 2022 |
|---|---|---|---|
| Total assets | 2 778 | 3 671 | 3 409 |
| Equity | 222 | 589 | 574 |
| Long-term debt | 1 408 | 1 151 | 859 |
| Short-term debt | 1 147 | 1 931 | 1 977 |
| Total debt | 2 555 | 3 082 | 2 835 |
EBITDA margin
1.3%
This company
15.8%
Market median
-92% vs market
20202022
Equity ratio
16.8%
This company
38.2%
Market median
-56% vs market
20202022
Return on equity
-2.7%
This company
18.4%
Market median
-115% vs market
20202022
Net profit margin
-0.1%
This company
8.1%
Market median
-101% vs market
20202022
Asset turnover
3.90×
This company
1.12×
Market median
+248% vs market
20202022
Debt / equity
4.94×
This company
0.62×
Market median
-697% vs market
20202022
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
PH Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
CB Chief Executive Officer | Chief Executive Officer | 2021 – 2023 |
GA Chief Executive Officer | Chief Executive Officer | 2023 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Former (3) | ||
| Chairman | 2021 – 2023 | |
| Board of Directors | 2021 – 2023 | |
| Board of Directors | 2021 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 | |
| Company | 25% | 25% | 2022 | |
| Company | 25% | 25% | 2022 | |
| Company | 25% | 25% | 2022 | |
| Company | 25% | 25% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Apoinvest Holding As
FAGERSTRAND APOTEK AS Board members of FAGERSTRAND APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Huy Le Vo | Chief Executive Officer | 0 companies |
| Christina Brodersen Holst | Chief Executive Officer | 0 companies |
| Gulzeb Aziz | Chief Executive Officer | 0 companies |
| Vegard Hoff | Board of Directors | 0 companies |
| Morten Frogner | Chairman | 0 companies |
| Michael Roland Ecker | Chairman | 0 companies |
| Jan Arne Frogner | Board of Directors | 0 companies |
| Einar Mathias Teigen Rasch-Halvorsen | Board of Directors | 0 companies |